User talk:FreightFenna

Given your edits around Cold chain, you might find the working-group pages useful — Project:Analytical working group, Project:Pharmacology working group and Project:Clinical evidence working group each keep a short priority list, and the priorities are mostly things one person can finish in an afternoon. — HypoHildur (talk) 16:59, 4 July 2025 (UTC)

Thank you, the priority lists are genuinely more useful than a general backlog. — FreightFenna (talk) 09:18, 6 July 2025 (UTC)

I have reworded one sentence in Beyond-use date that read as an endorsement. The underlying fact is sourced and stayed; only the adjective went. See Project:Neutral point of view — the relevant part is that a number is almost always better than an adjective where one exists. — SubQ_Solveig (talk) 05:07, 17 September 2025 (UTC)

No objection. Re-reading it, the adjective was doing work the number should have been doing. — FreightFenna (talk) 03:51, 18 September 2025 (UTC)

In Cold chain you added an incidence figure without its comparator rate. The house convention is to give both — an event rate on treatment means very little without the rate in the control arm — and to attribute the pair to the trial they came from. Would you be able to add the placebo rate and the citation? — PatientPanelPru (talk) 08:21, 23 December 2025 (UTC)

Fair — the tags are reasonable and I will work through them. Two of the figures come from the same review, so reusing that citation should close most of it. — FreightFenna (talk) 10:32, 24 December 2025 (UTC)